Webinar
What's really happening with GLP-1s?
Understand who is using GLP-1s, how well they work, and why patients stop or restart treatment.
GLP-1s are among today’s most talked about drugs, but who is using them and how well are they working? Watch this webinar now where we explore findings from studies on GLP-1s using Truveta Data to reveal key trends in use, effectiveness, and access.
Watch the webinar for insight into:
- Capturing faster, more comprehensive insights with Truveta Data.
- Understanding the trends in GLP-1 use over time and across diverse demographics.
- Interpreting patterns of GLP-1 discontinuation and reinitiation and key influencing factors.
- Understanding differences in on-treatment weight change between tirzepatide and semaglutide for type 2 diabetes.
- Generating these types of insights for other drugs, diseases, or devices.
